Jack E. Henningfield

19.2k total citations · 1 hit paper
314 papers, 14.4k citations indexed

About

Jack E. Henningfield is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jack E. Henningfield has authored 314 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Physiology, 98 papers in Molecular Biology and 62 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jack E. Henningfield's work include Smoking Behavior and Cessation (141 papers), Nicotinic Acetylcholine Receptors Study (93 papers) and Neurotransmitter Receptor Influence on Behavior (56 papers). Jack E. Henningfield is often cited by papers focused on Smoking Behavior and Cessation (141 papers), Nicotinic Acetylcholine Receptors Study (93 papers) and Neurotransmitter Receptor Influence on Behavior (56 papers). Jack E. Henningfield collaborates with scholars based in United States, France and United Kingdom. Jack E. Henningfield's co-authors include Reginald V. Fant, Edward J. Cone, Neal L. Benowitz, Roland R. Griffiths, Stephen J. Heishman, Wallace B. Pickworth, Richard A. Meisch, Steven R. Goldberg, Donald R. Jasinski and Robert M. Keenan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jack E. Henningfield

306 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical verification of tobacco use and cessation

2002 1.6k citations Neal L. Benowitz, Karen Ahijevych et al. Nicotine & Tobacco Research profile →

Peers

Countries citing papers authored by Jack E. Henningfield

Since Specialization

Citations

This map shows the geographic impact of Jack E. Henningfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack E. Henningfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack E. Henningfield more than expected).

Fields of papers citing papers by Jack E. Henningfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack E. Henningfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack E. Henningfield. The network helps show where Jack E. Henningfield may publish in the future.

Co-authorship network of co-authors of Jack E. Henningfield

This figure shows the co-authorship network connecting the top 25 collaborators of Jack E. Henningfield. A scholar is included among the top collaborators of Jack E. Henningfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack E. Henningfield. Jack E. Henningfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Psychedelic research – Going global 2025 ·Journal of Psychopharmacology ·David J. Heal, Sharon L. Smith, Jack E. Henningfield	0
2	The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act 2023 ·Psychopharmacology ·Margaret Moline, Shoji Asakura, (unknown), Ishani Landry, Beatrice Setnik, Judy Ashworth, Jack E. Henningfield	15
3	Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health 2023 ·Journal of Psychoactive Drugs ·(unknown), B. Anderson, (unknown), Ann Berger, Roland R. Griffiths, Charles S. Grob, Jack E. Henningfield, Beatriz Caiuby Labate, Larissa J. Maier, M. Catherine Maternowska, Frank Weichold, David B. Yaden, Veronica Magar	9
4	Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling 2022 ·Neuropharmacology ·Jack E. Henningfield, Marion A. Coe, Roland R. Griffiths, (unknown), Ann Berger, Allison R. Coker, Sandra D. Comer, David J. Heal, Peter S. Hendricks, Charles D. Nichols, (unknown), Frank J. Vocci, Farah Zia	25
5	The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia 2021 ·Journal of Addiction Medicine ·Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, Walter C. Prozialeck, Kirsten E. Smith, Ornella Corazza, Jack E. Henningfield, Oliver Grundmann	23
6	Kratom as a substitute for opioids: Results from an online survey 2019 ·Drug and Alcohol Dependence ·Marion A. Coe, Janine L. Pillitteri, Mark A. Sembower, Karen K. Gerlach, Jack E. Henningfield	112
7	Conference on abuse liability and appeal of tobacco products: Conclusions and recommendations 2011 ·Drug and Alcohol Dependence ·Jack E. Henningfield, Dorothy K. Hatsukami, Mitch Zeller, Ellen Peters	44
8	Tobacco psychopharmacology and public health policy: It takes a community. 2011 ·Experimental and Clinical Psychopharmacology ·Jack E. Henningfield	5
9	Dissent over harm reduction for tobacco 2006 ·The Lancet ·Nigel Gray, Jack E. Henningfield	10
10	Clean cut cigarettes: fictitious launch foreshadows actual tobacco industry strategy 2006 ·Tobacco Control ·Jack E. Henningfield, Gregory N. Connolly, (unknown), Joseph G. Gitchell, John M Pinney	3
11	Toward a comprehensive long term nicotine policy 2005 ·Tobacco Control ·Nigel Gray, Jack E. Henningfield, Neal L. Benowitz, Gregory N. Connolly, Carolyn Dresler, K. Fagerström, M. J. Jarvis, Peter Boyle	78
12	Calorie restriction increases cigarette use in adult smokers 2004 ·Psychopharmacology ·Lawrence J. Cheskin, (unknown), Jack E. Henningfield, David A. Gorelick	51
13	Does menthol enhance the addictiveness of cigarettes? An agenda for research 2003 ·Nicotine & Tobacco Research ·Jack E. Henningfield, Neal L. Benowitz, Karen Ahijevych, Bridgette E. Garrett, Gregory N. Connolly, Geoffrey Ferris Wayne	68
14	Lack of evidence for context-dependent cocaine-induced sensitization in humans: Preliminary studies 1994 ·Pharmacology Biochemistry and Behavior ·Richard B. Rothman, David A. Gorelick, Michael H. Baumann, (unknown), Ronald I. Herning, Wallace B. Pickworth, (unknown), (unknown), (unknown), Jack E. Henningfield	43
15	Report of the Tobacco Policy Research Study Group on Tobacco Products 1992 ·Tobacco Control ·John Slade, Gregory N. Connolly, Ronald M. Davis, Clifford E. Douglas, Jack E. Henningfield, John R. Hughes, Lynn T. Kozlowski, (unknown)	5
16	Report of the Tobacco Policy Research Study Group on Adjunctive Medications for Managing Nicotine Dependence 1992 ·Tobacco Control ·John Slade, Gregory N. Connolly, Ronald M. Davis, Clifford E. Douglas, Jack E. Henningfield, John R. Hughes, Lynn T. Kozlowski, (unknown)	3
17	Smoking Relapse: A Review 1991 ·International Journal of the Addictions ·Janet Brigham, Jack E. Henningfield, Maxine L. Stitzer	29
18	Discriminative stimulus effects ofd-amphetamine, methylphenidate, and diazepam in humans 1991 ·Psychopharmacology ·Stephen J. Heishman, Jack E. Henningfield	78
19	Nicotine dependence 1990 ·Journal of General Internal Medicine ·Caroline Cohen, Jack E. Henningfield	1
20	Progress in understanding the relationship between the pharmacological effects of nicotine and human tobacco dependence 1988 ·Pharmacology Biochemistry and Behavior ·Jack E. Henningfield, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact